Generic Semaglutide in 2026: Why So Many Patients Are Watching This Market
Yes and no, and that is exactly why people are confused. In India, semaglutide generics are becoming real because Novo Nordisk’s patent on semaglutide expired there on March 20, 2026, opening the door for local drugmakers to launch lower-cost versions. Reuters reported approvals or launch plans from companies including Sun Pharma, Dr Reddy’s, and Zydus. … Read more